{"id":"https://openalex.org/W2145440976","doi":"https://doi.org/10.1345/aph.1g582","title":"Atomoxetine Versus Stimulants for Treatment of Attention Deficit/Hyperactivity Disorder","display_name":"Atomoxetine Versus Stimulants for Treatment of Attention Deficit/Hyperactivity Disorder","alternate_titles":[],"publication_year":2006,"publication_date":"2006-06-01","ids":{"openalex":"https://openalex.org/W2145440976","doi":"https://doi.org/10.1345/aph.1g582","mag":"2145440976","pmid":"https://pubmed.ncbi.nlm.nih.gov/16735655"},"language":"en","primary_location":{"id":"doi:10.1345/aph.1g582","doi":"https://doi.org/10.1345/aph.1g582","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1g582","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145440976"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076718197","display_name":"Aaron P. Gibson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aaron P Gibson","raw_affiliation_strings":["Psychiatric Pharmacy Practice Resident/MS Student, College of Pharmacy, The University of Texas at Austin, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Pharmacy Practice Resident/MS Student, College of Pharmacy, The University of Texas at Austin, Austin, TX","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085256875","display_name":"Tawny L Bettinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tawny L Bettinger","raw_affiliation_strings":["College of Pharmacy, The University of Texas at Austin","Tawny L Bettinger PharmD, Assistant Professor, College of Pharmacy, The University of Texas at Austin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy, The University of Texas at Austin","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Tawny L Bettinger PharmD, Assistant Professor, College of Pharmacy, The University of Texas at Austin","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113868985","display_name":"Nick C. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nick C Patel","raw_affiliation_strings":["College of Pharmacy and Department of Psychiatry, University of Cincinnati, Cincinnati, OH","Nick C Patel PharmD PhD, Assistant Professor, College of Pharmacy and Department of Psychiatry, University of Cincinnati, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy and Department of Psychiatry, University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]},{"raw_affiliation_string":"Nick C Patel PharmD PhD, Assistant Professor, College of Pharmacy and Department of Psychiatry, University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039235704","display_name":"M. Lynn Crismon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Lynn Crismon","raw_affiliation_strings":["College of Pharmacy, The University of Texas at Austin","M Lynn Crismon PharmD, Professor, College of Pharmacy, The University of Texas at Austin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy, The University of Texas at Austin","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"M Lynn Crismon PharmD, Professor, College of Pharmacy, The University of Texas at Austin","institution_ids":["https://openalex.org/I86519309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":5.9964,"has_fulltext":false,"cited_by_count":96,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9646242,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"40","issue":"6","first_page":"1134","last_page":"1142"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10826","display_name":"Behavioral and Psychological Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3204","display_name":"Developmental and Educational Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9909999966621399},{"id":"https://openalex.org/keywords/psychostimulants","display_name":"psychostimulants","score":0.9879999756813049},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9909999966621399},{"id":"https://openalex.org/keywords/amphetamine-salts","display_name":"amphetamine salts","score":0.7429999709129333},{"id":"https://openalex.org/keywords/oros-methylphenidate","display_name":"OROS methylphenidate","score":0.8899999856948853},{"id":"https://openalex.org/keywords/head-to-head-comparison","display_name":"head-to-head comparison","score":0.6150000095367432},{"id":"https://openalex.org/keywords/adhd-medication","display_name":"ADHD medication","score":0.5490000247955322},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6980000138282776},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.8550000190734863},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.8389999866485596}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.9923925995826721},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.9422765970230103},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7625377178192139},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.7440896034240723},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6855330467224121},{"id":"https://openalex.org/C2909253567","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine hydrochloride","level":5,"score":0.6445452570915222},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.5373427271842957},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.5070459842681885},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.48642444610595703},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4710794985294342},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.27876558899879456},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.27626511454582214},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17832592129707336},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1345/aph.1g582","doi":"https://doi.org/10.1345/aph.1g582","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1g582","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:16735655","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16735655","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Comparative Study"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.909.1690","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.909.1690","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://aop.sagepub.com/content/40/6/1134.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W10589707","https://openalex.org/W20185869","https://openalex.org/W23151974","https://openalex.org/W73658022","https://openalex.org/W75392665","https://openalex.org/W629283852","https://openalex.org/W1885050980","https://openalex.org/W1896744728","https://openalex.org/W1973531471","https://openalex.org/W1980494785","https://openalex.org/W1992297350","https://openalex.org/W1993327116","https://openalex.org/W2006058627","https://openalex.org/W2016442365","https://openalex.org/W2016483680","https://openalex.org/W2024532533","https://openalex.org/W2028480590","https://openalex.org/W2040513075","https://openalex.org/W2041413905","https://openalex.org/W2048481057","https://openalex.org/W2050006242","https://openalex.org/W2051258686","https://openalex.org/W2058706567","https://openalex.org/W2066201328","https://openalex.org/W2067292897","https://openalex.org/W2092202774","https://openalex.org/W2107031757","https://openalex.org/W2111065019","https://openalex.org/W2112484680","https://openalex.org/W2117062136","https://openalex.org/W2119599154","https://openalex.org/W2122518346","https://openalex.org/W2123910896","https://openalex.org/W2123980944","https://openalex.org/W2126090207","https://openalex.org/W2131627337","https://openalex.org/W2140513029","https://openalex.org/W2159011576","https://openalex.org/W2164549762","https://openalex.org/W2167062019","https://openalex.org/W2222886669","https://openalex.org/W2325902617","https://openalex.org/W2599734864","https://openalex.org/W2601578636","https://openalex.org/W2737496409","https://openalex.org/W2744661960","https://openalex.org/W2809218088","https://openalex.org/W4247039770","https://openalex.org/W4247445519","https://openalex.org/W4300870773"],"related_works":["https://openalex.org/W2066232148","https://openalex.org/W2460616234","https://openalex.org/W2367476440","https://openalex.org/W4413436707","https://openalex.org/W2367350603","https://openalex.org/W1603750557","https://openalex.org/W2579876071","https://openalex.org/W3120410164","https://openalex.org/W4211260601","https://openalex.org/W2130386846"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"identify,":[2],"review,":[3,32],"and":[4,33,59,93,116,128,153,155,171,190,205,222,229,242,251,269],"analyze":[5],"studies":[6,80,98],"comparing":[7,81],"atomoxetine":[8,19,82,117,127,170,204],"with":[9,11,83,160,197,224,275],"psychostimulants":[10,115,213],"the":[12,16,21,48,102,119,134,227,257],"intent":[13],"of":[14,18,24,86,108,121,231],"determining":[15],"role":[17],"in":[20,47,101,118,248,288],"pharmacologic":[22,218],"management":[23],"attention":[25,51],"deficit/hyperactivity":[26,52],"disorder":[27],"(ADHD).":[28],"DATA":[29,104],"SOURCES:":[30],"Primary,":[31],"meta-analysis":[34],"articles":[35],"were":[36,71,89,99,131,163,194],"identified":[37],"by":[38],"a":[39],"MEDLINE":[40],"search":[41,49,258],"(1966-December":[42],"2005).":[43],"MeSH":[44],"headings":[45],"used":[46],"include:":[50],"disorder,":[53],"ADHD,":[54,225],"atomoxetine,":[55],"stimulants,":[56],"psychostimulants,":[57,84],"methylphenidate,":[58],"amphetamine":[60,173],"salts.":[61],"Relevant":[62,91],"data":[63,95,280],"presented":[64],"at":[65,150,181],"professional":[66],"meetings":[67],"that":[68],"we":[69],"attended":[70],"also":[72],"identified.":[73],"STUDY":[74],"SELECTION":[75],"AND":[76],"EXTRACTION:":[77],"All":[78],"clinical":[79,240],"regardless":[85],"study":[87],"design,":[88],"evaluated.":[90],"efficacy":[92,228],"safety":[94,230,279],"from":[96],"these":[97,232],"included":[100],"discussion.":[103],"SYNTHESIS:":[105],"At":[106],"time":[107],"writing,":[109],"5":[110],"head-to-head":[111],"trials":[112,241],"had":[113],"compared":[114],"treatment":[120,219,266],"ADHD.":[122],"No":[123],"significant":[124,179],"difference":[125],"between":[126,203],"methylphenidate":[129,145,162],"immediate-release":[130],"found":[132],"on":[133,168,210,239],"ADHD":[135,268],"Rating":[136],"Scale":[137],"total":[138],"score.":[139],"Osmotic":[140],"oral":[141],"release":[142],"system":[143],"(OROS)":[144],"showed":[146,178],"significantly":[147,156,195],"greater":[148],"improvement":[149],"weeks":[151],"1":[152],"2,":[154],"more":[157],"patients":[158,250],"treated":[159],"OROS":[161],"classified":[164],"as":[165,216,226],"responders.":[166],"Patients":[167],"both":[169],"mixed":[172],"salts":[174],"extended-release":[175],"(MAS":[176],"XR)":[177],"improvements":[180],"endpoint":[182],"over":[183],"baseline;":[184],"however,":[185,277],"Swanson,":[186],"Kotkin,":[187],"Agler,":[188],"M-Flynn,":[189],"Pelham":[191],"(SKAMP)":[192],"scores":[193],"better":[196],"MAS":[198],"XR.":[199],"Tolerability":[200],"was":[201],"similar":[202],"stimulant":[206],"medications.":[207],"CONCLUSIONS:":[208],"Based":[209],"available":[211],"evidence,":[212],"are":[214,281],"regarded":[215],"first-line":[217],"for":[220,259,267],"children":[221],"adolescents":[223],"agents":[233],"have":[234,254],"been":[235],"well":[236],"established":[237],"based":[238],"extensive":[243],"naturalistic":[244],"use.":[245],"Adverse":[246],"effects":[247],"some":[249],"abuse":[252],"potential":[253],"led":[255],"to":[256,272,283],"new":[260],"treatments.":[261],"Atomoxetine":[262],"represents":[263],"an":[264],"alternative":[265],"is":[270],"unlikely":[271],"be":[273],"associated":[274],"abuse;":[276],"long-term":[278],"needed":[282],"further":[284],"establish":[285],"its":[286],"place":[287],"therapy.":[289]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145440976","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
